Skip to main content
. 2021 Dec 17;145(3):1069–1078. doi: 10.1093/brain/awab368

Table 1.

Case characteristics

Case Age of death (years) Age at onset (years) Disease duration (years) Gender PMI (h) Brain weight (g) Clinical diagnosis MND ApoE Comorbid pathological diagnoses
1 74 62 12 M 26 1125 PPA No 3,3 ADNC A3, B1, C3; moderate vascular disease
2 82 69 13 F 31 1250 PPA No UNK ADNC A1, B0, C2
3 71 55 15 F 19 910 PPA No 3,3 None
4 55 45 10 M 18 1430 PPA No 3,3 Pigment spheroid degeneration, basal ganglia and substantia nigra
5 65 52 13 F 5 810a bvFTD No 2,3 None
6 71 63 8 F 28 970 bvFTD Yes 3,4 Severe vascular disease
7 73 60 13 M 6 1370 PPA No 3,3 ADNC A1, B0, C0; moderate vascular disease
8 61 50 11 F UNK 840 PPA No 3,3 ADNC A1, B0, C0; hippocampal sclerosis
9 73 53 20 F 12 904 PPA No 3,3 ADNC A1, B1, C0; UMN degeneration
10 64 50 14 F 12 900 bvFTD No 3,3 ADNC, A1, B0, C0; PLS-like pathology

ADNC = Alzheimer’s disease neuropathological change; F = female; M = male; MND = motor neuron disease; PMI = post-mortem interval; UNK = unknown.

a

Fixed brain weight.